Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Vaccin Immunother. 2014;10(6):1557-67. doi: 10.4161/hv.27737. Epub 2014 Feb 4.

Commercializing diarrhea vaccines for travelers.

Author information

1
International Vaccination Center (IVC); Málaga, Spain; Department Medicine Preventive and Public Health; University of Malaga; Malaga, Spain.
2
International Vaccination Center (IVC); Málaga, Spain.
3
Department Medicine Preventive and Public Health; University of Malaga; Malaga, Spain.

Abstract

Continued growth in international travel and forecasts for a great increase in the number of people who travel from industrialized to emerging and developing countries make it necessary to develop and improve the capacity to provide health protection to travelers. Measures available to prevent some diseases include a currently limited number of marketed vaccines which represent extremely useful tools to protect travelers. Travelers very often experience diarrheal and gastrointestinal diseases for which some vaccines are available. Use of these vaccines should be evaluated based on traveler and travel destination and characteristics. Vaccines available include those against cholera, typhoid fever, hepatitis A, hepatitis E (only available in China), and rotavirus. The aim of this review is to provide an updated summary about each of the abovementioned vaccines that may be useful for making decisions regarding their use and assessing their indications in recommendations for travelers.

KEYWORDS:

cholera; commercializing vaccines; hepatitis A; hepatitis E; rotavirus; traveler’s diarrhea; typhoid fever; vaccines

PMID:
24496054
PMCID:
PMC5396228
DOI:
10.4161/hv.27737
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center